19-48758107-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_019113.4(FGF21):c.517G>C(p.Ala173Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000686 in 1,457,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019113.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGF21 | NM_019113.4 | c.517G>C | p.Ala173Pro | missense_variant | 4/4 | ENST00000593756.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGF21 | ENST00000593756.6 | c.517G>C | p.Ala173Pro | missense_variant | 4/4 | 1 | NM_019113.4 | P1 | |
FGF21 | ENST00000222157.5 | c.517G>C | p.Ala173Pro | missense_variant | 3/3 | 1 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 exomes AF: 0.00000415 AC: 1AN: 240896Hom.: 0 AF XY: 0.00000758 AC XY: 1AN XY: 131988
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1457798Hom.: 0 Cov.: 32 AF XY: 0.00000690 AC XY: 5AN XY: 725142
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The c.517G>C (p.A173P) alteration is located in exon 3 (coding exon 3) of the FGF21 gene. This alteration results from a G to C substitution at nucleotide position 517, causing the alanine (A) at amino acid position 173 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at